Clinical Trials Sponsored by Zhejiang Xiaoshan hospital

Total 2083 results

Xiaoqian Zhang

Not yet recruiting

Comparison of Detection Rates Between Two Commonly Used Bone Density Measurement Methods

Osteoporosis | Diagnosis | Quantitative Computed Tomography | Dual Energy X-ray Absorptiometry

China
Xiaoyan Jia

Recruiting

Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients (NGAL)

Chronic Kidney Disease-Mineral and Bone Disorder

China
Red Cross Hospital, Hangzhou, China
First People's Hospital of Hangzhou; Sir Run Run Shaw Hospital; Zhejiang Provincial... and other collaborators

Unknown

Voriconazole for IPA in Chinese Patients With COPD (VIA-COPD)

COPD | Invasive Pulmonary Aspergillosis

China
Zhejiang Hospital
Zhejiang University

Unknown

Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke (AHSCTIS)

Stroke

China
Xiaofan Wu

Unknown

Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation

Unstable Angina Pectoris | Coronary Stent Implantation

China
Second Affiliated Hospital, School of Medicine,...
Second Affiliated Hospital of Wenzhou Medical University; Zhejiang University; Red Cross Hospital, Hangzhou, China and other collaborators

Terminated

Efficacy and Safety of Salvianolic Acid on AIS

Stroke

China
Zhejiang Cancer Hospital

Recruiting

Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC

Extensive Stage Lung Small Cell Cancer

China
Zhejiang Cancer Hospital

Not yet recruiting

Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial

Metastatic Breast Cancer

China
Zhejiang Cancer Hospital

Recruiting

SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma

Biliary Tract Carcinoma

China
Zhejiang Cancer Hospital

Not yet recruiting

The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.

Breast Neoplasms

China
Zhejiang Cancer Hospital

Recruiting

Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy

Cholangiocarcinoma | Biliary Tract Tumor

China
Zhejiang Cancer Hospital

Recruiting

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

Gastric Cancer | Peritoneal Metastases | Ascites, Malignant

China
Zhejiang Cancer Hospital

Recruiting

ZR2 Sequential Immunochemotherapy for Newly Treated MCL

Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma

China
Zhejiang Cancer Hospital

Recruiting

Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer

Healthy | Gastric Cancer

China
Zhejiang Cancer Hospital

Recruiting

Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Zhejiang Cancer Hospital

Not yet recruiting

Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer

Advanced Colorectal Cancer

China
Zhejiang Cancer Hospital

Recruiting

Lenvatinib Combined With Tislelizumab and TACE Applied as Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma With High-risk Recurrence Factors

Hepatocellular Carcinoma | Oxaliplatin | TACE | Lenvatinib | Tislelizumab | Pharmorubicin

China
Zhejiang Cancer Hospital

Not yet recruiting

Combined Treatment of Treated Bile Duct Cancer (CHOL)

Bile Duct Cancer
Zhejiang Cancer Hospital

Not yet recruiting

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma
Zhejiang Cancer Hospital

Recruiting

A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC

Extensive Stage Small Cell Lung Cancer

China
Zhejiang Cancer Hospital

Recruiting

Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Recruiting

A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma

Renal Cell Carcinoma

China
Zhejiang Cancer Hospital

Recruiting

GOT Applied as Neoadjuvant Regimen for Patients of Resectable ICC With High-risk Factors of Recurrence (GOT)

Intrahepatic Cholangiocarcinoma

China
Zhejiang Cancer Hospital

Recruiting

Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Locally Advanced Gastric Cancer

China
Zhejiang Cancer Hospital

Recruiting

Radiotherapy Combined With Endostatin and Capecitabine for NPC

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Not yet recruiting

Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study

Histologically Confirmed Breast Cancer ,Diagnosis of Bone Metastasis
Zhejiang Cancer Hospital

Recruiting

Retrospective Study of Brachytherapy (RetroBT)

Uterine Cervical Neoplasms | Uterine Neoplasms | Ovarian Neoplasms | Vulvar Cancer | Vaginal Cancer | Brachytherapy | Gynecologic Neoplasm

China
Zhejiang Cancer Hospital

Recruiting

Dendrobium Huoshanense Suppository in Rectal Cancer

Locally Advanced Rectal Cancer

China
Zhejiang Cancer Hospital

Not yet recruiting

Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Zhejiang Cancer Hospital

Recruiting

Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis

Malignant Tumor

China
Zhejiang Cancer Hospital

Recruiting

The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma

Pancreatic Cancer

China
Zhejiang Cancer Hospital

Recruiting

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

Brain Metastases | NSCLC Stage IV | Immunotherapy

China
Zhejiang Cancer Hospital

Recruiting

Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study

Gastric Adenocarcinoma

China
Zhejiang Cancer Hospital

Recruiting

A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC

Head and Neck Neoplasms

China
Zhejiang Cancer Hospital

Completed

HFNC and Hypoxia/Desaturation During Radiofrequency Ablation Under Moderate Sedation: A Randomized Clinical Trial

Hypoxia | Propofol | Sedation Complication | Desaturation of Blood

China
Zhejiang Cancer Hospital

Active, not recruiting

A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure

Epithelial Ovarian Cancer

China
Zhejiang Cancer Hospital

Completed

Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block for Breast Cancer Surgery

Breast Cancer

China
Zhejiang Cancer Hospital

Completed

The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery

Ovarian Neoplasm Epithelial
Zhejiang Cancer Hospital

Completed

Whether Opioids Are Factor That Induced POD? (POD)

Postoperative Delirium

China
Zhejiang Cancer Hospital

Completed

The Role of Clean Intermittent Catheterization in Patients Undergoing Radiotherapy After Radical Hysterectomy for Cervical Cancer

Uterine Cervical Neoplasms

China
Zhejiang Cancer Hospital

Active, not recruiting

Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Zhejiang Cancer Hospital

Completed

Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study

Breast Cancer | PI3K/AKT/mTOR Pathway Mutation | Everolimus

China
Zhejiang Cancer Hospital

Unknown

Rituximab Combined With Chidamide and Lenalidomide for r/r AITL (AITL)

Angioimmunoblastic T-cell Lymphoma | Chemotherapy Effect | Chemotherapeutic Toxicity

China
Zhejiang Cancer Hospital

Unknown

A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer

Esophageal Cancer

China
Zhejiang Cancer Hospital

Unknown

Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test (CMTNCMB)

Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer

China
Zhejiang Cancer Hospital

Unknown

Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

China
Zhejiang Cancer Hospital

Unknown

Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy (CALORIE)

Breast Cancer
Zhejiang Cancer Hospital

Unknown

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

Cancer Pain

China
Zhejiang Cancer Hospital

Unknown

Individualized Pharmaceutical-care for Inpatients With Cancer Pain

Cancer Pain

China
Zhejiang Cancer Hospital

Unknown

Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer

Breast Cancer

3

Subscribe